The “wild west” days of manufacturing and selling cannabis products outside the sphere of regulatory influence are rapidly coming to an end.
The Department of Veterans Affairs has “an unpublished policy” stating that the office does not consider employment in industries related to marijuana as either reliable or stable. These are among the two most important criteria for determining creditworthiness and who qualifies to purchase a home.
There is really no portion of American life that the Hemp for Victory bill does not touch. It seeks to study the potential uses of hemp across all sectors of our economy.
Based on the SC Attorney General’s opinion, not only would the person possessing or handling hemp without a license be subject to criminal liability, the hemp they were in possession of could be subject to seizure by law enforcement.
Regardless of how the FDA will eventually regulate CBD, it is abundantly clear that CBD companies should not make medical/disease claims nor market their products as dietary supplements. Doing so at this point is simply foolish.
This article discusses the reasons for smokable hemp’s rapid rise in popularity, why the future of smokable hemp is vital to the hemp industry at large, and the ways in which its legal status is under attack in several states.
The entire hemp industry is anxiously awaiting guidance from the United States Department of Agriculture (USDA). This wait has created a vacuum of sorts that many state legislatures are beginning to fill.
As anyone involved in the cannabis industry is aware, the US Food and Drug Administration (FDA) held hearings on May 31, 2019. Ostensibly, the hearing was about “Products Containing Cannabis or Cannabis-Derived Compounds”. In reality, it was about cannabidiol (CBD) in foods, cosmetics, and dietary supplements.
The SBI contends that since hemp flower and marijuana flower can sometimes be indistinguishable, SB 315 would effectively legalize marijuana legal in North Carolina. We were not persuaded by this, or any of the other arguments SBI made that sought to limit the legal status of hemp in North Carolina.
I spoke with Elijah Wolfson of Time Magazine about CBD after the FDA hearing. We spoke about several issues, including how to regulate CBD for mass market consumption while protecting the integrity of the clinical drug trials process.